UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058063
Receipt number R000066206
Scientific Title Evaluation of the efficacy and safety of stimulated conduction system pacing in adult patients with congenital heart disease.
Date of disclosure of the study information 2025/06/03
Last modified on 2025/06/03 11:40:24

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of the efficacy and safety of stimulated conduction system pacing in adult patients with congenital heart disease.

Acronym

Conduction system pacing in adult congenital heart disease

Scientific Title

Evaluation of the efficacy and safety of stimulated conduction system pacing in adult patients with congenital heart disease.

Scientific Title:Acronym

Conduction system pacing in adult congenital heart disease

Region

Japan


Condition

Condition

Adult congenital heart disease

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To determine the usefulness of conduction system pacing for cardiac function in patients with complex adult congenital heart disease with bradycardia, using lead placement into the conduction system in conjunction with 3D mapping at the time of pacemaker implantation.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Comparison of the amount of change in ventricular ejection fraction before and after implantation in conduction system pacing and conventional apical pacing.

Key secondary outcomes

Acute success of conduction system pacing
Frequency of lead reinsertion
Change in ventricular ejection fraction before and after conduction system pacing


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) Patients aged 18 years and over with congenital heart disease who are attending or being admitted to the Department of Cardiology, Kyushu University Hospital.
(2) Patients who are judged to be suitable for a pacemaker due to bradycardia and who will undergo transvenous lead implantation.
(3) Patients who fully understand the study and give written consent.

Key exclusion criteria

(1) Patients with active infections.
(2) Patients with metal allergies.
(3) Patients who are pregnant or may become pregnant.
(4) Other patients deemed ineligible for participation in the study by the principal investigator.

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Tomomi
Middle name
Last name Nagayama

Organization

Kyushu University Hospital

Division name

Department of Cardiovascular Medicine

Zip code

812-8582

Address

3-1-1, Maidashi, Higashi-ku, Fukuoka, Japan

TEL

0926425360

Email

nagayama.tomomi.325@m.kyushu-u.ac.jp


Public contact

Name of contact person

1st name Tomomi
Middle name
Last name Nagayama

Organization

Kyushu University Hospital

Division name

Department of Cardiovascular Medicine

Zip code

812-8582

Address

3-1-1, Maidashi, Higashi-ku, Fukuoka, Japan

TEL

0926425360

Homepage URL


Email

nagayama.tomomi.325@m.kyushu-u.ac.jp


Sponsor or person

Institute

Kyushu University

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)

MEDTRONIC JAPAN CO., LTD.


IRB Contact (For public release)

Organization

Ethical Review Committee for Observational Research at the Medical District Department of Kyushu University

Address

3-1-1, Maidashi, Higashi-ku, Fukuoka, Japan

Tel

092-642-5082

Email

ijkseimei@jimu.kyushu-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 06 Month 03 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2025 Year 05 Month 13 Day

Date of IRB

2025 Year 05 Month 13 Day

Anticipated trial start date

2025 Year 05 Month 13 Day

Last follow-up date

2029 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

The procedure flow at the time of pacemaker implantation should be performed as in normal practice and data collected at that time.
At the time of the pacemaker check performed as an outpatient 1 week, 1 month and 1 year after implantation, lead sensitivity, threshold and wave height fluctuations and ventricular pacing rate should be checked.
Perform echocardiography or cardiac MRI one year after implantation to assess changes in ventricular ejection fraction after pacemaker implantation.


Management information

Registered date

2025 Year 06 Month 03 Day

Last modified on

2025 Year 06 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066206